Compare TDOC & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TDOC | WGS |
|---|---|---|
| Founded | 2002 | 2017 |
| Country | United States | United States |
| Employees | N/A | 1300 |
| Industry | Medical/Nursing Services | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2015 | N/A |
| Metric | TDOC | WGS |
|---|---|---|
| Price | $7.34 | $59.92 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 7 |
| Target Price | $7.56 | ★ $120.71 |
| AVG Volume (30 Days) | ★ 3.8M | 1.3M |
| Earning Date | 04-29-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 80.58 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,406,840,000.00 | N/A |
| Revenue This Year | $1.19 | $29.98 |
| Revenue Next Year | $1.25 | $25.92 |
| P/E Ratio | ★ N/A | $1,251.58 |
| Revenue Growth | ★ 18.41 | N/A |
| 52 Week Low | $4.40 | $32.21 |
| 52 Week High | $9.77 | $170.87 |
| Indicator | TDOC | WGS |
|---|---|---|
| Relative Strength Index (RSI) | 58.34 | 61.72 |
| Support Level | $6.88 | $56.24 |
| Resistance Level | $7.39 | $73.46 |
| Average True Range (ATR) | 0.42 | 3.92 |
| MACD | -0.03 | 1.73 |
| Stochastic Oscillator | 50.93 | 83.83 |
Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp. The Integrated Care segment provides virtual healthcare solutions, including primary care, mental health, chronic care management, and telehealth enablement services for employers, insurers, and healthcare systems, mainly on a business-to-business basis, while the BetterHelp segment offers direct-to-consumer online mental health services, including counseling and therapy delivered through digital platforms. It generates the majority of its revenue from the Integrated Care segment.
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.